GSK Tries To Chase Down Pfizer With Phase III Pentavalent Meningococcal Vaccine Data

Phase III data for a vaccine combining Bexsero and Menveo demonstrated non-inferiority. GSK hopes to file it for approval soon, while Pfizer’s candidate has an October FDA action date.